Similar to our analyses, these studies adjusted their outcome for baseline participant characteristics, such as country of origin, socioeconomic status, current CD4+ cell count and CD4/CD8 ratio, years on ART, presence of diabetes, chronic kidney disease, and metabolic disease [5]. This evidence concerns the gene CD4 and metabolic disease.